Resource Center

More information?
More information?
25 RESULTS FOUND
AdvaMedDx Statement at CMS Clinical Laboratory Public Meeting July 2014
July 14, 2014
Comments
Protecting Access to Medicare Act of 2014 (PAMA) Implementation Letter to CMS June 2014
June 23, 2014
Letter
Protecting Access to Medicare Act of 2014 (PAMA) Implementation Letter to CMS May 2014
May 16, 2014
Letter
Comments to FDA on Self-Monitoring Blood Glucose Test Systems for Over-the-Counter Use
May 7, 2014
Comments
Comments to FDA on Blood Glucose Monitoring Test Systems for Prescription Point-of-Care Use 
May 4, 2014
Comments
Letter to National Correct Coding Initiative Policy Manual Revisions Regarding In Situ Hybridization
March 31, 2014
Letter
Clinical Laboratory Coalition Letter to Senate Leadership on Cuts to Medicare's Clinical Laboratory Fee Schedule
February 26, 2014
Letter
Clinical Laboratory Coalition Letter to House Leadership on Cuts to Medicare's Clinical Laboratory Fee Schedule
February 26, 2014
Letter
Summary of Clinical Laboratory Provisions in the Protecting Access to Medicare Act of 2014
January 1, 2014
Summary
AdvaMedDx CY 2014 Clinical Laboratory Fee Schedule Preliminary Payment Determinations and MAAA Codes Comments
October 25, 2013
Comments
CMS FAQ's on LDTs and CLIA
October 22, 2013
Fact Sheet
FDA Report on Paving the Way for Personalized Medicine
October 1, 2013
Study
AdvaMed Physician Fee Schedule Comments 
September 6, 2013
Comments
AdvaMed Outpatient Prospective Payment System Comments
September 6, 2013
Comments
AdvaMedDx Sunshine Brochure for Teaching Hospitals
August 8, 2013
Fact Sheet
Clinical Laboratory Coalition Letter on Office of Inspector General Study on Lab Test Payment Rates 
July 11, 2013
Letter
AdvaMedDx Statement for 2013 Clinical Laboratory Public Meeting
July 10, 2013
Comments
AdvaMedDx Support Letter for HR 2085
May 30, 2013
Letter
Clinical Laboratory Coalition Letter on Cuts to Clinical Lab Fee Schedule in President's Budget
April 16, 2013
Letter
Comments to FDA on Enrichment Strategies for Clinical Trials to Support Approval of Human Drugs and Biological Products 
March 18, 2013
Comments
Comments to FDA on Highly Multiplex Microbiological/Medical Countermeasure In Vitro Nucleic Acid Based Diagnostic Devices
February 7, 2013
Comments
Letter to CMS on Payment for Molecular Diagnostic Services
February 5, 2013
Letter
Comments to FDA on CLIA Waiver Applications
November 12, 2012
Comments
Letter to CMS Regarding Clinical Laboratory Fee Schedule Preliminary Payment Determinations and Multianalyte Assays with Algorithmic Analysis
September 28, 2012
Letter
Letter of Support for HR 3497, the Modernizing Our Drug and Diagnostics Evaluation and Regulatory Network Cures Act, and HR 6446, the Improving Diagnostic Innovations Act
September 24, 2012
Letter

Pages